Login

Ownership

13F as of Q2 2026 · 154.7M shares outstanding

Who owns Centessa Pharmaceuticals plc?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 1 holders own 4.8%
General Atlantic Cooperatief U.A. 4.8%
Institutional ownership
0.0%
-96.1 pts vs last qtr
Institutional holders
0
-161 vs last qtr
Net shares bought
−148.6M
by institutions in Q2 2026
New / sold out
0 / 161
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • Medicxi Ventures Management (Jersey) Ltd SOLD OUT −20.0M
  • Avoro Capital Advisors LLC SOLD OUT −11.4M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$124M
11 notices from 5 people
Shares covered
5.2M
3.36% of the company
Arranged in advance
8%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$57.2M$114.4MDec 2025: $593.0K under a 10b5-1 planDecJan 2026: $114.4M without a planJanFebMar 2026: $9.0M under a 10b5-1 planMarAprMayJunJulAugSepOctNov
Largest proposed sellers
  • Saurabh Saha Former officer $113M
  • Anderson Karen M. Officer 10b5-1 $6.37M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+45.3%
+13.26% a year
Each share's claim on the business
−31.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $119M
over 4 fiscal years
Diluted shares, split-adjusted
90.6M113.8M137.1M2022: 93.4M shares'222023: 96.2M shares'232024: 114.5M shares'242025: 135.7M shares'25
Buybacks Stock-based comp
$0$16.8M$33.5M2022 buybacks: $02022 stock comp: $25.0M'222023 buybacks: $02023 stock comp: $29.4M'232024 buybacks: $02024 stock comp: $33.5M'242025 buybacks: $02025 stock comp: $31.0M'25

How patient are the owners?

No 13F manager reports holding Centessa Pharmaceuticals plc.

Super Investors

Investment managers reporting Centessa Pharmaceuticals plc on Form 13F
MV
Medicxi Ventures Management (Jersey) Ltd
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
AC
Avoro Capital Advisors LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

3 more super investors behind a free account

See every manager holding Centessa Pharmaceuticals plc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Centessa Pharmaceuticals plc on Form N-PORT; together they hold 17.6% of the company
SW
SMALLCAP World Fund Inc
Position value
$176M
% of company
2.86%
% of the fund
0.22%
As of
March 31, 2026
SB
Fidelity Select Portfolios
Position value
$58.8M
% of company
1.41%
% of the fund
1.10%
As of
February 28, 2026

23 more funds behind a free account

See every fund holding Centessa Pharmaceuticals plc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
GA
General Atlantic Cooperatief U.A.
5%+ holder13D · 5.0%
Shares
7.4M
% of company
4.76%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support